C4B and neoplasm: As with clonal hematopoiesis related myeloid malignancies, secondary mutations in clonal hematopoietic cells (CH mutations) could also result in the accumulation of cells with immunosuppressive mutations (Fig. 1), thus inhibiting an effective anti-tumor immune response.